Preparation for a phase I/II study using autologous gene modified T lymphocytes for treatment of metastatic renal cancer patients.

Subjects

Subjects :

CD4 Antigens biosynthesis
Humans
Immunoglobulin Variable Region biosynthesis
Lymphocyte Activation
Recombinant Fusion Proteins biosynthesis
Transfection methods
Transplantation, Autologous
CD4 Antigens genetics
Carcinoma, Renal Cell immunology
Carcinoma, Renal Cell therapy
Genetic Therapy adverse effects
Immunoglobulin Variable Region genetics
Kidney Neoplasms immunology
Kidney Neoplasms therapy
Lymphocyte Transfusion adverse effects
T-Lymphocytes immunology

Details

Language :

English

ISSN :

0065-2598

Volume :

451

Database :

MEDLINE

Journal :

Advances in experimental medicine and biology

Publication Type :

Academic Journal

Accession number :

10026926

Full Text :

https://doi.org/10.1007/978-1-4615-5357-1_85